Patents by Inventor Bing Zheng

Bing Zheng has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10060593
    Abstract: A daytime running lamp (1) for being retrofitted on a road vehicle, comprising a reflector (4) with a reflective surface (5) for reflecting light in a general direction (I) of illumination and a plurality of light sources (3) arranged in a pattern having an extension along a horizontal axis (A). The light emitted by the plurality of light sources (3) has directional components in two opposite horizontal directions (H1, H2) along the horizontal axis (A) and a directional component in a vertical direction (V) perpendicular to the horizontal axis (A). The reflective surface (5) has a curvature such that the directional component in the vertical direction (V) is directed towards the general direction (I) of illumination, and the directional component in at least one of the horizontal directions (H1, H2) upon reflection in the reflective surface (5) is substantially unchanged by the reflection.
    Type: Grant
    Filed: July 30, 2014
    Date of Patent: August 28, 2018
    Assignee: Koninklijke Philips N.V.
    Inventors: Hua Bing Zheng, Albrecht Johannes Kraus, Matthias Daniel Epmeier
  • Publication number: 20180201679
    Abstract: The present invention is directed to compositions of matter useful for the treatment of hematopoietic tumor in mammals and to methods of using those compositions of matter for the same.
    Type: Application
    Filed: November 3, 2017
    Publication date: July 19, 2018
    Inventors: Yvonne Chen, Mark Dennis, Kristi Elkins, Jagath Reddy Junutula, Andrew Polson, Bing Zheng
  • Publication number: 20180204998
    Abstract: A solder-free sensing device includes a connecting assembly and a sensor. The connecting assembly includes a main body and at least two connecting pins engaged in the main body. The main body defines a receiving groove to receive the sensor. The sensor includes a first electrode layer and a second electrode layer insulated from the first electrode layer. Each connecting pin includes an end portion and an extending portion extending from the end portion. The end portion of each connecting pin is engaged in the receiving groove. The extending portion of each connecting pin extends through the main body to the outside of the main body. The sensor is electrically coupled to an external system by the at least two connecting pins.
    Type: Application
    Filed: May 10, 2017
    Publication date: July 19, 2018
    Inventor: XIAO-BING ZHENG
  • Publication number: 20180199917
    Abstract: An ultrasonic sensing device is foldable and includes two bracket portions rotatably connected and an ultrasonic sensor on each bracket portion. The ultrasonic sensor includes a flexible circuit board carrying an ultrasonic signal transmitting element and an ultrasonic signal receiving element. The ultrasonic signal transmitting element is mounted to one of the two bracket portions, and the ultrasonic signal receiving element is mounted to other of the two bracket portions. The ultrasonic signal transmitting element is capable of rotating to the ultrasonic signal receiving element by opening and closing the two bracket portions.
    Type: Application
    Filed: March 31, 2017
    Publication date: July 19, 2018
    Inventor: XIAO-BING ZHENG
  • Patent number: 9896506
    Abstract: The present invention is directed to compositions of matter useful for the treatment of hematopoietic tumor in mammals, including immunoconjugates comprising anti-CD79b cysteine-engineered antibody huMA79b.v28, and to methods of using those compositions of matter for the same.
    Type: Grant
    Filed: June 9, 2015
    Date of Patent: February 20, 2018
    Assignee: GENENTECH, INC.
    Inventors: Yvonne Chen, Mark Dennis, David Dornan, Kristi Elkins, Jagath Reddy Junutula, Andrew Polson, Bing Zheng
  • Publication number: 20180044421
    Abstract: The invention provides anti-CLL-1 antibodies and immunoconjugates and methods of using the same.
    Type: Application
    Filed: July 24, 2017
    Publication date: February 15, 2018
    Applicant: Genentech, Inc.
    Inventors: Bing Zheng, Andrew Polson, Cecilia Chiu, Wei-Ching Liang, Yan Wu
  • Publication number: 20180044420
    Abstract: The invention provides anti-CLL-1 antibodies and immunoconjugates and methods of using the same.
    Type: Application
    Filed: July 24, 2017
    Publication date: February 15, 2018
    Applicant: Genentech, Inc.
    Inventors: Bing Zheng, Andrew Polson, Cecilia Chiu, Wei-Ching Liang, Yan Wu
  • Publication number: 20180015179
    Abstract: The invention provides anti-CD79b antibodies and immunoconjugates and methods of using the same.
    Type: Application
    Filed: June 26, 2017
    Publication date: January 18, 2018
    Applicant: Genentech, Inc.
    Inventors: Paul Polakis, Andrew G. Polson, Susan Diane Spencer, Shang-Fan Yu, Bing Zheng
  • Publication number: 20180009894
    Abstract: The invention provides anti-CLL-1 antibodies and immunoconjugates and methods of using the same.
    Type: Application
    Filed: July 24, 2017
    Publication date: January 11, 2018
    Applicant: Genentech, Inc.
    Inventors: Bing Zheng, Andrew Polson, Cecilia Chiu, Wei-Ching Liang, Yan Wu
  • Publication number: 20170362318
    Abstract: The present invention is directed to compositions of matter useful for the treatment of hematopoietic tumor in mammals and to methods of using those compositions of matter for the same.
    Type: Application
    Filed: January 13, 2017
    Publication date: December 21, 2017
    Inventors: Craig Crowley, Frederic J. De Sauvage, Dan L. Eaton, Allen Ebens, JR., Kristi Elkins, Jo-Anne S. Hongo, Jagath Reddy Junutula, Andrew Polson, Sarajane Ross, Victoria Smith, Richard L. Vandlen, Bing Zheng
  • Patent number: 9845355
    Abstract: The present invention is directed to anti-CD79b antibodies with specific hypervariable region sequences in the heavy and light chain variable domains as enumerated in the SEQ ID NOs described herein.
    Type: Grant
    Filed: July 15, 2008
    Date of Patent: December 19, 2017
    Assignee: Genentech, Inc.
    Inventors: Yvonne Chen, Mark Dennis, Kristi Elkins, Jagath Reddy Junutula, Andrew Polson, Bing Zheng
  • Publication number: 20170348422
    Abstract: The invention relates generally to a silvestrol molecule activated with a leaving group. The invention further relates generally to an antibody-drug conjugate comprising an antibody conjugated by a linker to one or more silvestrol drug moieties and methods of treatment.
    Type: Application
    Filed: June 5, 2017
    Publication date: December 7, 2017
    Applicant: Genentech, Inc.
    Inventors: Thomas Pillow, Andrew G. Polson, Bing Zheng
  • Publication number: 20170326248
    Abstract: The invention provides anti-CD22 antibodies and immunoconjugates and methods of using the same.
    Type: Application
    Filed: April 26, 2017
    Publication date: November 16, 2017
    Applicant: GENENTECH, INC
    Inventors: Paul Polakis, Andrew G. Polson, Susan Diane Spencer, Shang-Fan Yu, Bing Zheng
  • Patent number: 9778656
    Abstract: Included are embodiments for multimode vehicular navigation control. Some embodiments include a vehicle that has a memory component and a vehicle control module (VCM), where the VCM includes a controller. Additionally, the memory component may store functional modes of operation and control modes of operation, each of the control modes of operation being associated with a mechanism for controlling the vehicle, and each of the functional modes of operation being associated with a desired function of the vehicle. In some embodiments the VCM receives control commands from a system operator and implements the control commands, utilizing the controller. In some embodiments, at least one of the control modes of operation is configured for automatic control of the vehicle and at least one of the control modes of operation is a torque control mode for providing a power signal directly to a vehicle motor, without utilization of the controller.
    Type: Grant
    Filed: September 25, 2012
    Date of Patent: October 3, 2017
    Assignee: Crown Equipment Corporation
    Inventors: Lucas B. Waltz, Bing Zheng, Thomas L. Mallak, Steve Mangette
  • Patent number: 9751946
    Abstract: The invention provides anti-CLL-1 antibodies and immunoconjugates and methods of using the same.
    Type: Grant
    Filed: September 11, 2015
    Date of Patent: September 5, 2017
    Assignee: Genentech, Inc.
    Inventors: Bing Zheng, Andrew Polson, Cecilia Chiu, Wei-Ching Liang, Yan Wu
  • Publication number: 20170058032
    Abstract: The present invention is directed to compositions of matter useful for the treatment of hematopoietic tumor in mammals and to methods of using those compositions of matter for the same.
    Type: Application
    Filed: November 11, 2016
    Publication date: March 2, 2017
    Applicant: Genentech, Inc.
    Inventors: Yvonne CHEN, Mark DENNIS, David DORNAN, Kristi ELKINS, Jagath Reddy JUNUTULA, Andrew POLSON, Bing ZHENG
  • Publication number: 20160368994
    Abstract: The present invention relates to anti-CLL-1 antibodies including anti-CLL-1 antibodies comprising a CLL-1 binding domain and a CD3 binding domain (e.g., anti-CLL-1/CD3 T cell dependent bispecific (TDB) antibody) and methods of using the same.
    Type: Application
    Filed: June 14, 2016
    Publication date: December 22, 2016
    Applicant: Genentech, Inc.
    Inventors: Robert F. Kelley, Steven R. Leong, Wei-Ching Liang, Mary Mathieu, Andrew G. Polson, Bing Zheng, Xiaocheng Chen, Cecilia Pui Chi Chiu, Mark S. Dennis, Allen Ebens, Yan Wu
  • Publication number: 20160186951
    Abstract: A daytime running lamp (1) for being retrofitted on a road vehicle, comprising a reflector (4) with a reflective surface (5) for reflecting light in a general direction (I) of illumination and a plurality of light sources (3) arranged in a pattern having an extension along a horizontal axis (A). The light emitted by the plurality of light sources (3) has directional components in two opposite horizontal directions (H1, H2) along the horizontal axis (A) and a directional component in a vertical direction (V) perpendicular to the horizontal axis (A). The reflective surface (5) has a curvature such that the directional component in the vertical direction (V) is directed towards the general direction (I) of illumination, and the directional component in at least one of the horizontal directions (H1, H2) upon reflection in the reflective surface (5) is substantially unchanged by the reflection.
    Type: Application
    Filed: July 30, 2014
    Publication date: June 30, 2016
    Inventors: Hua Bing Zheng, Albrecht Johannes Kraus, Matthias Daniel Epmeier
  • Patent number: 9360484
    Abstract: The present invention is directed to compositions of matter useful for the treatment of hematopoietic tumor in mammals and to methods of using those compositions of matter for the same.
    Type: Grant
    Filed: November 12, 2013
    Date of Patent: June 7, 2016
    Assignee: GENENTECH, INC.
    Inventors: Kristi Elkins, Andrew Polson, Allen Ebens, Camelia Adams, Bing Zheng, Jagath R. Junutula, Jo-Anne Hongo, Yan Wu
  • Publication number: 20160075787
    Abstract: The invention provides anti-CLL-1 antibodies and immunoconjugates and methods of using the same.
    Type: Application
    Filed: September 11, 2015
    Publication date: March 17, 2016
    Applicant: GENENTECH, INC.
    Inventors: Bing Zheng, Andrew Polson, Cecilia Chiu, Wei-Ching Liang